Transamerica Financial Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.66M | Buy |
5,061
+3,773
| +293% | +$3.83M | 0.4% | 63 |
|
|
2025
Q4 | $1.38M | Buy |
1,288
+599
| +87% | +$573K | 0.12% | 160 |
|
|
2025
Q3 | $525K | Buy |
689
+637
| +1,225% | +$474K | 0.04% | 232 |
|
|
2025
Q2 | $40.3K | Sell |
52
-7,021
| -99% | -$5.46M | ﹤0.01% | 316 |
|
|
2025
Q1 | $5.84M | Sell |
7,073
-260
| -4% | -$216K | 0.6% | 35 |
|
|
2024
Q4 | $5.66M | Sell |
7,333
-202
| -3% | -$167K | 0.56% | 41 |
|
|
2024
Q3 | $6.67M | Sell |
7,535
-1,760
| -19% | -$1.58M | 0.65% | 33 |
|
|
2024
Q2 | $8.42M | Hold |
9,295
| – | – | 0.9% | 19 |
|
|
2024
Q1 | $7.23M | Buy |
9,295
+6,668
| +254% | +$4.75M | 0.74% | 25 |
|
|
2023
Q4 | $1.53M | Buy |
2,627
+1,386
| +112% | +$809K | 0.21% | 81 |
|
|
2023
Q3 | $667K | Buy |
1,241
+2
| +0.2% | +$1.03K | 0.09% | 147 |
|
|
2023
Q2 | $581K | Buy |
1,239
+1,212
| +4,489% | +$508K | 0.08% | 165 |
|
|
2023
Q1 | $9K | Sell |
27
-2,993
| -99% | -$1.01M | ﹤0.01% | 323 |
|
|
2022
Q4 | $1.1M | Buy |
3,020
+72
| +2% | +$25.5K | 0.16% | 119 |
|
|
2022
Q3 | $954K | Buy |
2,948
+360
| +14% | +$114K | 0.14% | 122 |
|
|
2022
Q2 | $839K | Buy |
2,588
+2,585
| +86,167% | +$776K | 0.12% | 135 |
|
|
2022
Q1 | $1K | Hold |
3
| – | – | 0.04% | 87 |
|
|
2021
Q4 | $1K | Hold |
3
| – | – | 0.03% | 96 |
|
|
2021
Q3 | $1K | Sell |
3
-1
| -25% | -$247 | 0.03% | 95 |
|
|
2021
Q2 | $1K | Sell |
4
-11
| -73% | -$2.21K | 0.02% | 147 |
|
|
2021
Q1 | $3K | Buy |
15
+1
| +7% | +$196 | 0.07% | 60 |
|
|
2020
Q4 | $3K | Hold |
14
| – | – | 0.06% | 59 |
|
|
2020
Q3 | $2K | Sell |
14
-10,928
| -100% | -$1.69M | 0.04% | 105 |
|
|
2020
Q2 | $1.8M | Buy |
10,942
+10,931
| +99,373% | +$1.68M | 0.39% | 52 |
|
|
2020
Q1 | $2K | Sell |
11
-1
| -8% | -$137 | 0.04% | 60 |
|
|
2019
Q4 | $2K | Buy |
12
+2
| +20% | +$232 | 0.03% | 76 |
|
|
2019
Q3 | $2K | Sell |
10
-6,191
| -100% | -$689K | 0.03% | 76 |
|
|
2019
Q2 | $687K | Buy |
6,201
+6,193
| +77,413% | +$729K | 0.15% | 107 |
|
|
2019
Q1 | $1K | Sell |
8
-4,383
| -100% | -$533K | 0.01% | 89 |
|
|
2018
Q4 | $509K | Sell |
4,391
-1,062
| -19% | -$119K | 0.13% | 103 |
|
|
2018
Q3 | $586K | Buy |
5,453
+216
| +4% | +$21.6K | 0.12% | 119 |
|
|
2018
Q2 | $447K | Buy |
5,237
+5,225
| +43,542% | +$429K | 0.1% | 125 |
|
|
2018
Q1 | $1K | Hold |
12
| – | – | ﹤0.01% | 405 |
|
|
2017
Q4 | $1K | Sell |
12
-6
| -33% | -$511 | ﹤0.01% | 384 |
|
|
2017
Q3 | $2K | Sell |
18
-10
| -36% | -$820 | ﹤0.01% | 319 |
|
|
2017
Q2 | $3K | Sell |
28
-1
| -3% | -$82 | ﹤0.01% | 278 |
|
|
2017
Q1 | $3K | Sell |
29
-11
| -28% | -$881 | ﹤0.01% | 272 |
|
|
2016
Q4 | $3K | Sell |
40
-113
| -74% | -$8.41K | ﹤0.01% | 279 |
|
|
2016
Q3 | $13K | Sell |
153
-23
| -13% | -$1.84K | ﹤0.01% | 249 |
|
|
2016
Q2 | $14K | Sell |
176
-41,476
| -100% | -$3.12M | ﹤0.01% | 243 |
|
|
2016
Q1 | $3M | Buy |
41,652
+2,372
| +6% | +$179K | 0.25% | 87 |
|
|
2015
Q4 | $3.31M | Buy |
39,280
+1,908
| +5% | +$158K | 0.24% | 81 |
|
|
2015
Q3 | $3.13M | Sell |
37,372
-19,185
| -34% | -$1.62M | 0.25% | 81 |
|
|
2015
Q2 | $4.72M | Buy |
56,557
+4,171
| +8% | +$318K | 0.34% | 54 |
|
|
2015
Q1 | $3.81M | Buy |
52,386
+7,090
| +16% | +$505K | 0.27% | 64 |
|
|
2014
Q4 | $3.13M | Buy |
45,296
+4,622
| +11% | +$312K | 0.25% | 54 |
|
|
2014
Q3 | $2.64M | Buy |
40,674
+164
| +0.4% | +$10.4K | 0.24% | 60 |
|
|
2014
Q2 | $2.52M | Buy |
40,510
+3,038
| +8% | +$181K | 0.22% | 67 |
|
|
2014
Q1 | $2.21M | Buy |
37,472
+3,908
| +12% | +$218K | 0.22% | 62 |
|
|
2013
Q4 | $1.71M | Buy |
33,564
+5,413
| +19% | +$271K | 0.19% | 70 |
|
|
2013
Q3 | $1.42M | Buy |
28,151
+6,580
| +31% | +$344K | 0.18% | 76 |
|
|
2013
Q2 | $1.06M | Buy |
+21,571
| New | +$1.17M | 0.17% | 69 |
|
Other funds holding LLY
VCM
VPM
Transamerica Financial Advisors's LLY Position: Q1 2026 in Review
Transamerica Financial Advisors increased its Eli Lilly (LLY) stake by 293% in Q1 2026, buying an estimated $3.83M and bringing the position to 5,061 shares worth $4.66M. The position accounts for 0.4% of the portfolio, ranked #63.
Transamerica Financial Advisors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.42M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Transamerica Financial Advisors held 5,061 shares of Eli Lilly worth $4.66M as of Q1 2026.
- Transamerica Financial Advisors bought 3,773 Eli Lilly shares in Q1 2026, an estimated $3.83M.
- Eli Lilly made up 0.4% of Transamerica Financial Advisors's portfolio in Q1 2026, its #63 holding.
- Transamerica Financial Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Transamerica Financial Advisors's Eli Lilly position peaked at $8.42M in Q2 2024.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Transamerica Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.